Tocqueville Asset Management L.P. trimmed its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 65.5% in the 3rd quarter, HoldingsChannel reports. The fund owned 4,221 shares of the biotechnology company’s stock after selling 8,029 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Biogen were worth $1,085,000 at the end of the most […]
Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 15.000-16.000 for the period, compared to the consensus earnings per share estimate of 15.650. The company issued revenue guidance of -. Biogen also updated its FY24 guidance to $15.00-$16.00 […]
Greenleaf Trust lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 10.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 1,790 shares of the biotechnology company’s stock after purchasing an additional 171 shares during the period. Greenleaf Trust’s holdings in Biogen were worth $460,000 as of its most recent […]
Navellier & Associates Inc. bought a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,164 shares of the biotechnology company’s stock, valued at approximately $556,000. Other institutional investors have […]
Navellier & Associates Inc. acquired a new stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,164 shares of the biotechnology company’s stock, valued at approximately $556,000. A number of […]